Metabolic imaging with hyperpolarized [1-13C] pyruvate in patient-derived preclinical mouse models of breast cancer

by Susana Ros, Alan J. Wright, Alejandra Bruna, Carlos Caldas, Kevin M. Brindle
Published 2021-09-01

Recommendations from the ERAS® Society for standards for the development of enhanced recovery after surgery guidelines

by M. Brindle, G. Nelson, D. N. Lobo, O. Ljungqvist, U. O. Gustafsson
Published 2020-02-01

Small bowel angioectasia as a marker of frailty and poor prognosis

by Alexander R. Robertson, Anastasios Koulaouzidis, William M. Brindle, Andrew J. Robertson, John N. Plevris
Published 2020-06-01

Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent

by Zoltan Szucs, James Joseph, Tim J. Larkin, Bangwen Xie, Sarah E. Bohndiek, Kevin M. Brindle, André A. Neves
Published 2021-02-01

Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent

by Zoltan Szucs, James Joseph, Tim J. Larkin, Bangwen Xie, Sarah E. Bohndiek, Kevin M. Brindle, André A. Neves
Published 2021-03-01

Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients

by Florent Mouliere, Richard Mair, Dineika Chandrananda, Francesco Marass, Christopher G Smith, Jing Su, James Morris, Colin Watts, Kevin M Brindle, Nitzan Rosenfeld
Published 2018-12-01

A Comparison between Radiolabeled Fluorodeoxyglucose Uptake and Hyperpolarized 13C-Labeled Pyruvate Utilization as Methods for Detecting Tumor Response to Treatment

by Timothy H. Witney, Mikko I. Kettunen, Samuel E. Day, De-en Hu, Andre A. Neves, Ferdia A. Gallagher, Sandra M. Fulton, Kevin M. Brindle
Published 2009-06-01

18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography

by Flaviu Bulat, Friederike Hesse, De-En Hu, Susana Ros, Connor Willminton-Holmes, Bangwen Xie, Bala Attili, Dmitry Soloviev, Franklin Aigbirhio, Finian. J. Leeper, Kevin M. Brindle, André A. Neves
Published 2020-12-01

Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.

by Thomas C Booth, Timothy J Larkin, Yinyin Yuan, Mikko I Kettunen, Sarah N Dawson, Daniel Scoffings, Holly C Canuto, Sarah L Vowler, Heide Kirschenlohr, Michael P Hobson, Florian Markowetz, Sarah Jefferies, Kevin M Brindle
Published 2017-01-01